CRISTINA RIOS: Open Payments
NPI 1629733126 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 24 payments from 9 companies in 2025. Trend: 2023 $40 · 2024 $826 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $404 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| CVRx, Inc. | 1 | $29 |
| AtriCure, Inc. | 1 | $26 |
| Medtronic, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
Products named: Ozempic, Wegovy, Kerendia, WAINUA, ONPATTRO, Barostim Neo System, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, ENTRESTO.
Industry payments across FL — which companies pay providers there.
